Acessibilidade / Reportar erro

Spirometry evaluation in patient with tuberculosis sequelae treated by lobectomy

Abstracts

OBJECTIVE: To evaluate pre and post-operative spirometry in patients with tuberculosis sequelae undergoing lobectomy. METHODS: We selected 20 patients, aged between 15 and 56 years, of both genders, with a history of tuberculosis treatment, with repeated infections or hemoptysis and indication of pulmonary lobectomy. The tuberculosis treatment time was six months, and onset of symptoms, between one and 32. We evaluated and compared vital capacity (VC), forced vital capacity (FVC), forced expiratory volume (FEV1), the FEV1/FVC, forced expiratory flow (FEF) and peak expiratory flow (PEF) preoperatively and after the first, third and sixth postoperative months (POM). The significance level (á) used in all tests was 5%, ie, it was considered significant when p <0.05. RESULTS: The averages found were: Vital Capacity (VC) - Preoperative: 2.83; 1st POM: 2.12; 3rd POM: 2.31; 6th POM: 2.43. Forced Vital Capacity (FVC) - Preoperative: 2.97; 1st POM: 2.21; 3rd POM: 2.35; 6th POM: 2.53. Expiratory Volume in 1 second (FEV1) - Preoperative: 2.23; 1st POM: 1.75; 3rd POM: 1.81; 6th POM 1.97. There was marked decrease in lung function in the first month after surgery, but there was an improvement of the parameters from the third month, with gradual increase up to the sixth month. CONCLUSION: There was no recovery of preoperative spirometric parameters at six months postoperatively in patients with sequelae of tuberculosis submitted to lobectomy.

pneumonectomy; Tuberculosis; Spirometry; Preoperative care; Postoperative care


OBJETIVO: Avaliar a espirometria no pré e pós-operatório de doentes com sequela de tuberculose, submetidos à lobectomia. MÉTODOS: Foram selecionados 20 doentes, com idade entre 15 e 56 anos, de ambos os sexos, com história pregressa de tratamento de tuberculose, apresentando infecção de repetição ou hemoptises. Foram submetidos à lobectomia pulmonar. O tempo de tratamento da tuberculose foi seis meses e o aparecimento dos sintomas entre um e 32 anos. Foram avaliadas a capacidade vital (CV), a capacidade vital forçada (CVF), o volume expiratório forçado (VEF1), o VEF1/CVF, o fluxo expiratório forçado (FEF) e o pico de fluxo expiratório (PFE) após o primeiro, terceiro e sexto meses em relação ao pré-operatório. O nível de significância (á) aplicado em todos os testes foi 5%, ou seja, considerou-se significativo quando p<0,05. RESULTADOS: As Médias encontradas foram as seguintes: Capacidade Vital (CV) Pré-operatória-2,83 ; 1º PO 2,12; 3º PO 2,31; 6º PO 2,43. Capacidade Vital Forçada (CVF) Pré-operatória- 2,97; 1º PO 2,21; 3º PO 2,35; 6º PO 2,53. Volume Expiratório no 1º Segundo (VEF1) Pré-operatório 2,23; 1º PO 1,75; 3º PO 1,81; 6º PO 1,97. Houve diminuição acentuada das funções respiratórias no primeiro mês de pós-operatório, porém houve melhora dos parâmetros a partir do terceiro mês, com progressivo aumento até o sexto mês de pós-operatório. CONCLUSÃO: Não houve recuperação dos parâmetros espirométricos, comparados aos do pré operatório, após seis meses de pós-operatório nos pacientes com sequela de tuberculose submetidos à lobectomia.

Pneumonectomia; Tuberculose; Espirometria; Cuidados pré-operatórios; Cuidados pós-operatórios


ORIGINAL ARTICLE

Spirometry evaluation in patient with tuberculosis sequelae treated by lobectomy

Elias AmorimI; Roberto Saad Junior, TCBC-SPII; Roberto StirbulovIII

IStaff Physician, University Hospital, Federal University of Maranhão

IIProfessor, Thoracic Surgery, Department of Surgery, Faculty of Medical Sciences of the São Paulo Wholly Home

IIIAssociate Professor, Pulmonology, Department of Internal Medicine, Faculty of Medical Sciences of the São Paulo Wholly Home

Address correspondence to Address correspondence to: Elias Amorim E-mail: amorimelm@gmail.com

ABSTRACT

OBJECTIVE: To evaluate pre and post-operative spirometry in patients with tuberculosis sequelae undergoing lobectomy.

METHODS: We selected 20 patients, aged between 15 and 56 years, of both genders, with a history of tuberculosis treatment, with repeated infections or hemoptysis and indication of pulmonary lobectomy. The tuberculosis treatment time was six months, and onset of symptoms, between one and 32. We evaluated and compared vital capacity (VC), forced vital capacity (FVC), forced expiratory volume (FEV1), the FEV1/FVC, forced expiratory flow (FEF) and peak expiratory flow (PEF) preoperatively and after the first, third and sixth postoperative months (POM). The significance level (á) used in all tests was 5%, ie, it was considered significant when p <0.05.

RESULTS: The averages found were: Vital Capacity (VC) - Preoperative: 2.83; 1st POM: 2.12; 3rd POM: 2.31; 6th POM: 2.43. Forced Vital Capacity (FVC) - Preoperative: 2.97; 1st POM: 2.21; 3rd POM: 2.35; 6th POM: 2.53. Expiratory Volume in 1 second (FEV1) - Preoperative: 2.23; 1st POM: 1.75; 3rd POM: 1.81; 6th POM 1.97. There was marked decrease in lung function in the first month after surgery, but there was an improvement of the parameters from the third month, with gradual increase up to the sixth month.

CONCLUSION: There was no recovery of preoperative spirometric parameters at six months postoperatively in patients with sequelae of tuberculosis submitted to lobectomy.

Key words: Pneumonectomy. Tuberculosis. Spirometry. Preoperative care. Postoperative care.

INTRODUCTION

Tuberculosis (TB) caused by Mycobacterium tuberculosis, or M. tuberculosis, is still common in countries like Brazil1. It reaches the 21st century as a public health problem and remains unsolved, with significant morbidity and mortality2. It is the most common infectious disease in humans3, killing nearly three million people worldwide each year4. Tuberculosis is perhaps the oldest disease known to mankind, with records of injuries found in vertebrae of mummies from about four thousand years ago1,5-10.

Modern chemotherapy promoted remarkable reduction of tuberculosis. The specific treatment, initiated in 1944 with the discovery of streptomycin, followed in 1952 with isoniazid11,12.

The most common sequelae are destroyed lung, bronchiectasis, fungal ball, and tracheal stenosis13-15.

The pulmonary function and ventilation test, or spirometry, is very important for the indications of operative treatment. It is used to evaluate the conditions of mortality and anesthetic procedures.

There are few references in the literature regarding changes in pulmonary function after parenchymal resection in tuberculosis.

The Faculty of Medical Sciences of the São Paulo Wholly Home (FCMSCSP), pursuant to on of its lines of research, is developing studies on pulmonary function, both pre-operative and postoperative. Many of these works have been completed16-19.

The aim of this study was to evaluate the results of spirometry in patients undergoing thoracotomy for lobectomy as treatment of sequelae of tuberculosis.

METHODS

This study was approved by the Research Ethics Committee of the University Hospital, Federal University of Maranhão at Presidente Dutra County.

We selected 20 patients, ten men and ten women, with a previous history of TB treatment who had symptomatic sequelae, ie, recurrent infection or hemoptysis, who sought the Clinic of Thoracic Surgery, University Hospital of Presidente Dutra, Federal University of Maranhão, From September 2007 to February 2010.

The age of patients ranged from 15 to 56 years, the treatment time was six months, and the onset of symptoms, between one and 32 years after treatment.

After medical interview, with reports of recurrent hemoptysis and a history of tuberculosis treated, were requested chest radiography and computed tomography (CT).

With the radiological diagnosis of sequel, the following preoperative tests were then performed: perfusion-ventilation scintigraphy, research of alcohol-acid resistant bacilli (AFB) in sputum, red blood cells, cardiac evaluation, and pulmonary function test.

The volume-time curve obtained by forced spirometry was performed in compliance with the criteria established by the American Thoracic Society20 and the best three acceptable curves were chosen. From there, we obtained the values of forced vital capacity (FVC), forced expiratory volume in one second (FEV1), FEV1/FVC, forced expiratory flow between 25% and 75% of FVC (FEF 25-75%), peak forced expiratory flow (PEF). The normal reference values used for all curves were proposed by Pereira et al. 21.

The evaluation of the effect of lobectomy in the variables (VC, FVC, FEV1, FEV1/FVC, FEF and PEF) after the first, third and sixth months compared to preoperative values was performed using the paired t test. The significance level (á) used in all tests was 5%, ie, it was considered significant when p <0.05.

RESULTS

Imaging tests (chest radiography and CT) confirmed the diagnosis of fungal ball and bronchiectasis of the segments to be operated.

The ventilation-perfusion scintigraphy showed pulmonary perfusion deficit in the diseased segments, researches for AFB were negative, given that this was an exclusion criterion. Cardiac evaluation, blood counts and pulmonary function tests were all consistent with the performance of surgery.

Figure 1 depicts the mean values of VC with the standard deviations and calculated values of p for comparison between pre-and postoperative periods. It is observed that in all three comparisons (pre and first month, pre and third month, and pre and sixth month) there were significant differences (p <0.05) between the means of the two moments.


Figure 2 shows the mean values of FVC with comparison between the same three pairs of moments. There were statistically significant differences when comparing the four moments (p <0.05).


As for VEF1, There was no statistically significant difference (p> 0.05) between the preoperative and six-month postoperative periods, the opposite occurring for the other comparisons (pre and first month and pre and third month - p <0.050), with progressive recovery values (Figure 3).


In Figure 4 we find the average of PEF of the four periods: preoperative and the three postoperative. There was a statistically significant difference (p <0.05) among all comparisons with baseline PEF, indicating that by the sixth month there was full recovery of variable PEF.


DISCUSSION

Spirometry involves carrying out measures of lung volumes and flows that are obtained during the movements of inspiration and forced expiration; the device then transforms them into numbers and graphs. It is essential in cases of surgical resection, especially in lung operations, as it can help predict the risk of postoperative complications.

In this work, we have chosen spirometry due to it being the mostly used method in surgical practice, its availability at the hospital, and the difficulty of getting other methods. The disease incidence is still high in the state of Maranhão, with large numbers of symptomatic sequelae.

FVC is considered the most important measure of spirometry because it represents the maximum flow of air exhaled after maximal inspiration, held at the shortest interval of time. Any process that alters the dynamic pulmonary also alters the maximum flow, being the measurement most sensitive to variation. In restrictive ventilatory disorders, FVC displays values †below the reference ones.

FEV1 is the volume obtained in one second expiratory FVC; it is the most representative spirometric measurement of clinical alterations and restrictive ventilatory disturbances; it may be normal or reduced.

Perin19 compared spirometric evaluation of patients who underwent abdominoplasty in the immediate preoperative and 19 and 36 postoperative months and showed no significant difference with the correction of rectus abdominis muscles.

This work showed marked decrease in lung function in the first month after surgery, attributed to the great difficulty of the patient to perform the maneuvers due to the trauma of the chest wall muscles and the pain associated with respiratory effort.

Helene Junior18 assessed respiratory function in patients who underwent abdominoplasty in the preoperative period and in the fourth POD, and observed reduced respiratory function on the fourth POD, with normalization at the 30th day.

According to Tercan et al.22, VC presents significant postoperative improvement until the 30th day in abdominoplasty, though not reaching preoperative values.

In this study, the improvement in lung function was observed from the third postoperative month on due to the absence of pain and improved lung compliance, with progressive recovery of the parameters in the sixth month.

This study sought to assess whether there was total recovery of spirometric parameters within 180 days after lobectomy. The results did not show significant recovery of parameters, reaching the preoperative average. This occurred only in measures of FEV1/FVC and FEF.

The present study is the first to investigate the profile of patients with sequelae of tuberculosis by evaluating spirometry in the pre and postoperative periods of lobectomy. Further studies should be performed in longer periods, of a year or more, to verify whether the reason for this change is due to the specific lung segment operated.

Thus, we conclude that, after six postoperative months, patients with tuberculosis sequelae submitted to lobectomy did not present with spirometric parameters recovery when compared to preoperative values.

REFERENCES

1. Campos CA, Marchiori E, Rodrigues R. Tuberculose pulmonar: achados na tomografia computadorizada de alta resolução do tórax em pacientes com doença em atividade comprovada bacteriologicamente. J Pneumologia. 2002;28(1):23-9.

2. Muniz JN, Ruffino-Netto A, Villa TCS, Yamamura M, Arcencio R, Cardozo-Gonzales RI. Aspectos epidemiológicos da co-infecção tuberculose e vírus da imunodeficiência humana em Ribeirão Preto (SP), de 1998 a 2003. J bras pneumol. 2006;32(6):529-34.

3. Bombarda S, Figueiredo CM, Funari MBG, Soares Junior J, Seiscento M, Terra Filho M. Imagem em tuberculose pulmonar. J Pneumologia. 2001;27(6):329-40.

4. Ribeiro SA. Tratamento compulsório da tuberculose: avanço ou retrocesso? J Pneumologia. 2003;29(1):50-2. (Cartas)

5. Silveira MPT, Adorno RFR, Fontana T. Perfil dos pacientes com tuberculose e avaliação do Programa Nacional de Controle da Tuberculose em Bagé (RS). J bras pneumol. 2007;33(2):199-205.

6. Ruffino-Netto A. Tuberculose: a calamidade negligenciada. Rev Soc Bras Med Trop. 2002;35(1):51-8.

7. Cavalcanti ZR, Albuquerque MFPM, Campello ARL, Ximenes R, Montarroyos U, Verçosa MKA. Característica da tuberculose em idosos no Recife (PE): contribuição para o programa de controle. J bras pneumol. 2006;32(6):535-43.

8. Brasil. Ministério da Saúde. Tuberculose no Brasil: avanços e perspectivas. Programa Nacional de Controle da Tuberculose. [online]. In: Seminário de Manejo Clínico da Tuberculose, São Paulo, 02 e 03 de setembro de 2010. [cited 2010 out 23] Available from: http://www.sam.pmrp.com.br/ssaude/programas/tuberculose/tuberculose_no_brasil.pdf

9. Castelo Filho A, Kritski AL, Barreto AW, Lemos ACM, Ruffino-Netto A, Guimarães CA, et al. II Consenso Brasileiro de Tuberculose. Diretrizes Brasileiras para Tuberculose 2004. J bras pneumol. 2004;30(supl. 1):S2-56.

10. Fernandes TM. Sol e trevas: histórias sociais da tuberculose brasileira. Hist cienc saude-Manguinhos. 2004;11(3):767-71.

11. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004;169(11):1181-6.

12. Gazetta CE, Vendramini SHF, Ruffino-Netto A, Oliveira MRC, Villa TCS. Estudo descritivo sobre a implantação da estratégia de tratamento de curta duração diretamente observado no controle da tuberculose em São José do Rio Preto e seus impactos (1998-2003). J bras pneumol. 2007;33(2):192-8.

13. Gomes Neto A, Medeiros ML, Gifoni JMM. Bronquiectasia localizada e multissegmentar: perfil clínico-epidemiológico e resultado do tratamento cirúrgico de 67 casos. J Pneumologia. 2001;27(1):1-6.

14. Guerra MS, Miranda JA, Leal F, Vouga L. Tratamento cirúrgico das bronquiectasias. Rev Port Pneumol. 2007;13(5):691-701.

15. Balkanli K, Genç O, Dakak M, Gürkök S, Gözübüyük A, Caylak H, et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg. 2003;24(5):699-702.

16. Saad Júnior R, Garrido T, Stirbulov R, Rafal F. Avaliação da função respiratória de doentes submetidos à operação abdominal alta. Rev Col Bras Cir. 1994;21(6):329-32.

17. Pinto AMR. Estudo comparativo da função pulmonar em pacientes pós-revascularizados do miocárdio, com CEC e sem CEC, com uso de derivação intraluminal [tese]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 1999.

18. Helene Júnior A. Avaliação da função respiratória em indivíduos submetidos à abdominoplastia. [tese]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 2005.

19. Perin LF. Avaliação espirométrica de indivíduos submetidos à dermolipectomia abdominal. [dissertação]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 2007.

20. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-36.

21. Pereira CAC. Testes de função pulmonar. Projeto Diretrizes. Associação Médica Brasileira e Conselho Federal de Medicina. [on line]. Sociedade Brasileira de Pneumologia e Tisiologia. Elaboração final: 16 de abril de 2001. 12p. [citado em: 2010 out 20]. Disponível em: http://www.projetodiretrizes.org.br/projeto_diretrizes/090.pdf

22. Tercan M, Bekerecioglu M, Dikensoy O, Kocoglu H, Atik B, Isik D, et al. Effects of abdominoplasty on respiratory functions: a prospective study. Ann Plast Surg. 2002;49(6):617-20.

Received on 20/06/2012

Accepted for publication 07/08/2012

Conflict of interest: none

Source of funding: none

Work performed at the University Hospital of the Federal University of Maranhão at Presidente Dutra, Maranhao State, Brazil.

  • 1. Campos CA, Marchiori E, Rodrigues R. Tuberculose pulmonar: achados na tomografia computadorizada de alta resolução do tórax em pacientes com doença em atividade comprovada bacteriologicamente. J Pneumologia. 2002;28(1):23-9.
  • 2. Muniz JN, Ruffino-Netto A, Villa TCS, Yamamura M, Arcencio R, Cardozo-Gonzales RI. Aspectos epidemiológicos da co-infecção tuberculose e vírus da imunodeficiência humana em Ribeirão Preto (SP), de 1998 a 2003. J bras pneumol. 2006;32(6):529-34.
  • 3. Bombarda S, Figueiredo CM, Funari MBG, Soares Junior J, Seiscento M, Terra Filho M. Imagem em tuberculose pulmonar. J Pneumologia. 2001;27(6):329-40.
  • 4. Ribeiro SA. Tratamento compulsório da tuberculose: avanço ou retrocesso? J Pneumologia. 2003;29(1):50-2. (Cartas)
  • 5. Silveira MPT, Adorno RFR, Fontana T. Perfil dos pacientes com tuberculose e avaliação do Programa Nacional de Controle da Tuberculose em Bagé (RS). J bras pneumol. 2007;33(2):199-205.
  • 6. Ruffino-Netto A. Tuberculose: a calamidade negligenciada. Rev Soc Bras Med Trop. 2002;35(1):51-8.
  • 7. Cavalcanti ZR, Albuquerque MFPM, Campello ARL, Ximenes R, Montarroyos U, Verçosa MKA. Característica da tuberculose em idosos no Recife (PE): contribuição para o programa de controle. J bras pneumol. 2006;32(6):535-43.
  • 8. Brasil. Ministério da Saúde. Tuberculose no Brasil: avanços e perspectivas. Programa Nacional de Controle da Tuberculose. [online]. In: Seminário de Manejo Clínico da Tuberculose, São Paulo, 02 e 03 de setembro de 2010. [cited 2010 out 23] Available from: http://www.sam.pmrp.com.br/ssaude/programas/tuberculose/tuberculose_no_brasil.pdf
  • 9. Castelo Filho A, Kritski AL, Barreto AW, Lemos ACM, Ruffino-Netto A, Guimarães CA, et al. II Consenso Brasileiro de Tuberculose. Diretrizes Brasileiras para Tuberculose 2004. J bras pneumol. 2004;30(supl. 1):S2-56.
  • 10. Fernandes TM. Sol e trevas: histórias sociais da tuberculose brasileira. Hist cienc saude-Manguinhos. 2004;11(3):767-71.
  • 11. Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004;169(11):1181-6.
  • 12. Gazetta CE, Vendramini SHF, Ruffino-Netto A, Oliveira MRC, Villa TCS. Estudo descritivo sobre a implantação da estratégia de tratamento de curta duração diretamente observado no controle da tuberculose em São José do Rio Preto e seus impactos (1998-2003). J bras pneumol. 2007;33(2):192-8.
  • 13. Gomes Neto A, Medeiros ML, Gifoni JMM. Bronquiectasia localizada e multissegmentar: perfil clínico-epidemiológico e resultado do tratamento cirúrgico de 67 casos. J Pneumologia. 2001;27(1):1-6.
  • 14. Guerra MS, Miranda JA, Leal F, Vouga L. Tratamento cirúrgico das bronquiectasias. Rev Port Pneumol. 2007;13(5):691-701.
  • 15. Balkanli K, Genç O, Dakak M, Gürkök S, Gözübüyük A, Caylak H, et al. Surgical management of bronchiectasis: analysis and short-term results in 238 patients. Eur J Cardiothorac Surg. 2003;24(5):699-702.
  • 16. Saad Júnior R, Garrido T, Stirbulov R, Rafal F. Avaliação da função respiratória de doentes submetidos à operação abdominal alta. Rev Col Bras Cir. 1994;21(6):329-32.
  • 17. Pinto AMR. Estudo comparativo da função pulmonar em pacientes pós-revascularizados do miocárdio, com CEC e sem CEC, com uso de derivação intraluminal [tese]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 1999.
  • 18. Helene Júnior A. Avaliação da função respiratória em indivíduos submetidos à abdominoplastia. [tese]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 2005.
  • 19. Perin LF. Avaliação espirométrica de indivíduos submetidos à dermolipectomia abdominal. [dissertação]. São Paulo: Santa Casa de Misericórdia de São Paulo, Faculdade de Ciências Médicas; 2007.
  • 20. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107-36.
  • 22. Tercan M, Bekerecioglu M, Dikensoy O, Kocoglu H, Atik B, Isik D, et al. Effects of abdominoplasty on respiratory functions: a prospective study. Ann Plast Surg. 2002;49(6):617-20.
  • Address correspondence to:

    Elias Amorim
    E-mail:
  • Publication Dates

    • Publication in this collection
      07 June 2013
    • Date of issue
      Apr 2013

    History

    • Received
      20 June 2012
    • Accepted
      07 Aug 2012
    Colégio Brasileiro de Cirurgiões Rua Visconde de Silva, 52 - 3º andar, 22271- 090 Rio de Janeiro - RJ, Tel.: +55 21 2138-0659, Fax: (55 21) 2286-2595 - Rio de Janeiro - RJ - Brazil
    E-mail: revista@cbc.org.br